Phillip Phan, a professor of strategy and entrepreneurship at the Carey Business School, discusses promising developments in telemedicine that may have been sped up by the onset of the coronavirus pandemic
Regulations against corporate collusion have been relaxed to help manufacturing during coronavirus pandemic, but will firms do the right thing when the viral threat is over?
Johns Hopkins lecturer Bonnie Robeson, who led drug discovery and development during AIDS epidemic, shares why scientists should prioritize finding a suitable therapy for COVID-19 as well as a vaccine
Thomas Rid, SAIS faculty expert on cybersecurity and disinformation, discusses the efforts by foreign countries to influence the public's understanding of the COVID-19 pandemic
Achieving herd protection can stop the spread of an infectious disease within a population, but as Bloomberg School experts explain, the U.S. is nowhere near that point with SARS-CoV-2, and getting there could prove difficult